SHP626

· Mirum Pharmaceuticals, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for SHP626, covering 2016-12-07 to 2016-12-07. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Tolerability Study of SHP626 in Overweight and Obese Adults [Phase 1]